Skip to content
Homepage
Clinic directory

Clinics in Beverly Hills, Michigan

Every listing is checked against federal records, reviewed for evidence, and confirmed still operating. No pay-to-play. No guesswork.

  • No results found.
  • No results found.

Beverly Hills, MI

Stem Cell Therapy clinics in Beverly Hills

Beverly Hills supports a regenerative medicine market shaped by both private clinics and regional academic medicine. Local referral networks run through Cedars-Sinai and UCLA Health, and stem cell practice in the area spans the Golden Triangle, Wilshire Corridor, and Beverly Hills medical offices. Patient demand splits across three buckets: orthopedic injections for active adults and aging athletes, neurological and autoimmune protocols marketed to longevity-focused patients, and IV-based allogeneic products offered by private wellness clinics. The FDA classifies most stem cell injections for orthopedic, neurological, or longevity use as investigational biologics under 21 CFR Part 1271, meaning they require either a Biologics License or an active Investigational New Drug authorization. Autologous bone marrow and adipose products may qualify as Section 361 when minimally manipulated and used for homologous function. SB 1004 (2017) requires written disclosure when stem cell therapy is not FDA-approved. The Medical Board of California regulates physician practice under Business and Professions Code 651. Proposition 71 (2004) established the California Institute for Regenerative Medicine (CIRM). The FDA secured a 2022 permanent injunction against the California Stem Cell Treatment Center over non-compliant adipose SVF products. The 20 Beverly Hills clinics listed below have been reviewed against our vetting criteria, including federal NPI lookup, OIG exclusion screening, and California Medical Board licensure checks.

1 Clinics

MD on staff

American Regenerative Clinic

Beverly Hills, MI

American Regenerative Clinic, a regenerative medicine clinic in Bingham Farms, offers stem-cell injection, prolotherapy, and ozone therapy—including 10-pass ozone protocols—for musculoskeletal and sy…

  • Ozone Therapy
  • IV Therapy
  • Laser Therapy (LLLT)
  • Hyperbaric Oxygen Therapy (HBOT)
  • Oxygen Therapy
15 30 50 results per page

Regulatory context

A note on Michigan's stem cell therapy rules.

Michigan cellular therapy is governed by 21 CFR Part 1271. Section 361 covers minimally manipulated HCT/Ps used for homologous use without premarket approval. Section 351 covers products that are more than minimally manipulated, used non-homologously, or combined with another article, and these require an IND for clinical use or a BLA for marketing. Most stem cell, stromal vascular fraction, and exosome therapies marketed in Michigan for orthopedic, neurologic, and longevity indications are Section 351 biologics that lack FDA approval. The state has both academic IND research programs and direct-to-patient regenerative clinics.

  • Michigan Public Health Code, MCL Chapter 333, Article 15
    Establishes physician licensure and discipline through the Michigan Board of Medicine and Board of Osteopathic Medicine and Surgery.
  • Michigan Pharmacy Act, MCL Chapter 333, Article 15, Part 177
    Regulates compounding pharmacies aligned with federal 503A and 503B standards.
  • Michigan Consumer Protection Act, MCL Chapter 445, Section 901-922
    Empowers the Attorney General to pursue deceptive marketing claims; healthcare exemption case law has narrowed application against licensed providers but does not protect false advertising.

The FDA has issued warning letters to Michigan clinics offering stem cell and exosome therapies. The Michigan Department of Licensing and Regulatory Affairs can discipline physicians through the Boards of Medicine and Osteopathic Medicine for unprofessional conduct including misleading regenerative medicine advertising. The Michigan Attorney General has pursued enforcement against providers making unsupported clinical claims, though the Smith v Globe Life decision has somewhat narrowed Consumer Protection Act application against licensed professionals. Federal warning letters apply nationally and Michigan clinics that source unapproved cellular products face the same regulatory exposure.

Stem Cell Therapy in Beverly Hills, answered.

Most stem cell therapies at private Beverly Hills clinics are not FDA-approved. The FDA has approved certain hematopoietic stem cell products for blood and immune disorders, but stem cell injections for orthopedic, neurological, or longevity use are generally investigational. They require a Biologics License or an active Investigational New Drug authorization, or they must qualify as Section 361 minimally manipulated and homologous-use products under 21 CFR Part 1271. SB 1004 (2017) requires written disclosure when stem cell therapy is not FDA-approved.

Beverly Hills sits in the premium metro tier. Single-joint autologous bone marrow or adipose injections typically run $5,000 to $15,000 per session. Systemic IV protocols using allogeneic umbilical cord or Wharton's jelly products range $10,000 to $25,000, and full multi-session protocols can reach $20,000 to $50,000. Exosome add-ons range $4,000 to $8,000. Insurance rarely covers these treatments because the FDA classifies most protocols as investigational.

Autologous stem cells come from your own body, usually harvested from bone marrow aspirate or adipose tissue and reinjected the same day. When minimally manipulated and used for homologous function, they often fall under FDA Section 361, which does not require pre-market approval. Allogeneic stem cells come from a donor source, most commonly umbilical cord blood or Wharton's jelly, and are generally classified as Section 351 biologics that require an active Investigational New Drug authorization. Beverly Hills clinic offerings span both categories, so ask which classification applies before treatment.

Yes. Research programs at Cedars-Sinai and UCLA Health periodically run FDA-authorized stem cell trials across orthopedics, neurology, cardiology, and oncology. Search clinicaltrials.gov and filter by Beverly Hills or the broader metro to see active recruiting studies. Trial participation is typically low-cost or free compared to commercial protocols and includes structured follow-up with imaging and lab monitoring.

Verify physician licensure through the California Medical Board and confirm the clinic's NPI number through the NPPES registry. Check the FDA warning letter database for the clinic name and the HHS Office of Inspector General exclusion list. Ask whether the treatment is Section 361 or Section 351, whether the clinic operates under an Investigational New Drug authorization for allogeneic or expanded products, and whether adverse events are tracked. Ask specifically about compliance with SB 1004.

Filters

Rating

Treatments

Advanced Therapies 1
Chronic, Immune & Hormonal
Digestive & Respiratory
IV & Infusion
Pain & Musculoskeletal
Skin & Aesthetics
Mental Health & Neurology